发明名称 Chimeric nucleic acid molecule with non-AUG translation initiation sequences
摘要 The present disclosure relates to nucleic acid vaccine compositions and methods for preventing or treating pathological conditions, such as cancer or infectious disease. Further, the disclosure provides methods for more efficient production of antigens via mRNA containing one or more non-conventional start codons to promote multiplex initiation of translation in eukaryotic cells.
申请公布号 US9364523(B2) 申请公布日期 2016.06.14
申请号 US201514660924 申请日期 2015.03.17
申请人 TapImmune Inc. 发明人 Florkiewicz Robert Z.
分类号 C12N15/63;C07H21/04;A61K39/00;A61K45/06;C07K14/705;C12N15/67 主分类号 C12N15/63
代理机构 Seed IP Law Group PLLC 代理人 Seed IP Law Group PLLC
主权项 1. A chimeric nucleic acid molecule, comprising a multiplex translation initiation (MTI) sequence comprising from two to about five translation initiation sites operatively linked in frame to a nucleic acid molecule encoding a fusion protein comprising from two to about ten eukaryotic folate receptor-alpha (FRα) antigenic peptides, wherein at least one of the MTI translation initiation sites is a non-AUG translation initiation site and the MTI allows the production of more than one mole of fusion protein per mole of mRNA.
地址 Jacksonville FL US